Celladon Gets $43M For Heart Failure Treatments
La Jolla-based Celladon Corporation, a developer of biopharmaceuticals targeting cardiovascular disease, said Wednesday afternoon that it has raised $43M in a financing round. The round was led by Pfizer Venture Investments, and also included ...
Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for ...PR Newswire (press release)
Celladon Raises $43M, Wins Fast-Track Status for Heart TreatmentXconomy
Corporate VCs crowd into $43M round for CelladonFierceBiotech

all 11 news articles »